01 Aug 2014
(MENAFN) A US biotech company pioneering tablets containing embedded microchips that can tell if patients have taken their medication said it has raised a further USD172 million, including funds from a firm part-owned by Abu Dhabi”s Mubadala Development Company, according to Arabian Business.
Privately held Proteus Digital Health, which is working with drugmakers including Novartis and Otsuka, said this week the funding was one of the biggest US private financings this year and the largest in the digital health sector and shows investor interest in its ingestible and wearable technology.
Proteus already has European and US approval for its “smart pill” technology system, in which a tiny sensor is embedded in a tablet and linked to a patch worn on the patient’s abdomen.
31 Aug 2025
BBK announces an exceptional 6-month grace period financing campaign for Personal and Car Finance customers
13 Aug 2025
BBK’s BD 5,000,000 Al Hayrat scheme awards BD 680,000 to 390 Al Hayrat winners in August and September
04 Aug 2025
HM the King’s Support for Youth is an Inspirational Model for Their Empowerment Journey
28 Jul 2025
BBK discloses its financial results for the half year ended 30th June 2025
20 Jul 2025
CBB approves the transfer of the retail banking operations of HSBC Bank Middle East, Bahrain Branch to BBK
08 Jul 2025
BBK proudly launches the third edition of “Grow” and welcomes 20 Bahraini graduates
03 Jul 2025
BBK hosts executive leadership session on digital assets in collaboration with Rain
02 Jul 2025
BBK launches the largest-ever Al Hayrat Prizes, offering BD 5 million to over 2,000 winners
This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more